Kloprogge F, Piola P, Dhorda M, Muwanga S, Turyakira E, et al.
2013-11-13 • CPT: Pharmacometrics and Systems Pharmacology
2013-11-13 • CPT: Pharmacometrics and Systems Pharmacology
Pregnancy alters the pharmacokinetic properties of many antimalarial compounds. The objective of this study was to evaluate the pharmacokinetic properties of lumefantrine in pregnant and...
Kloprogge F, Workman L, Borrmann S, Tekete M, Lefevre G, et al.
2018-06-12 • PLOS Medicine
2018-06-12 • PLOS Medicine
The fixed dose combination of artemether-lumefantrine (AL) is the most widely used treatment for uncomplicated Plasmodium falciparum malaria. Relatively lower cure rates and lumefantrine...
Tarning J, Kloprogge F, Dhorda M, Jullien V, Nosten F, et al.
2013-08-05 • Antimicrobial Agents and Chemotherapy
2013-08-05 • Antimicrobial Agents and Chemotherapy
ABSTRACTPregnancy alters the pharmacokinetic properties of many drugs used in the treatment of malaria, usually resulting in lower drug exposures. This i...
Nyang'wa BT, Kloprogge F, Moore DAJ, Bustinduy A, Motta I, et al.
2021-09-06 • BMJ Open
2021-09-06 • BMJ Open
INTRODUCTION Drug-resistant tuberculosis (TB) remains a global health threat, with little over 50% of patients successfully treated. Novel regimens like the ones being studied in the...